D&O Insurance: Shareholder's Friend or Foe?

  • When: April 12, 2007, 8:45 am - 5:00 pm

Recent research demonstrates the importance of Directors' and Officers' liability insurance to securities litigation. But this same research calls into question the value of D&O insurance for shareholders. Do shareholders need insurance protecting corporate assets when they can protect themselves by holding a diversified investment portfolio? Does D&O insurance protect shareholders by monitoring corporate governance and fighting frivolous claims? Or does D&O insurance allow managers to mislead the markets and shareholders with less fear of real consequences?

This conference brings together leaders from law and industry with academics conducting the latest research.

Attend the conference to learn about:

  • The latest research on D&O insurance,
  • The future of securities class actions,
  • The importance of D&O insurance to public markets,
  • Strategic and tactical challenges to D&O insurers in securities litigation,
  • The shareholder primacy challenge to entity coverage in the D&O policy.

Schedule

8:45 AM Welcome and introductions.
9:00 AM Does corporate governance matter to securities litigation risk?
10:45 AM The future of securities class actions.
1:15 PM Can insurers reduce securities litigation risk?
3:00 PM How do insurers manage the securities litigation process?
4:45 PM Concluding remarks: Implications for insurers and securities litigators.

Participants

  • Tom Baker (University of Connecticut)
  • Jeffrey Benner (Moody's Investors Service)
  • Martin Boyer (University of Montreal)
  • Zhiyan Cao (Yale University)
  • John Coffee (Columbia Law School)
  • Lawrence Cunningham (Boston College Law School)
  • Alicia Davis Evans (University of Michigan)
  • Jill Fisch (Fordham University)
  • Sean Fitzpatrick (Chubb)
  • Steven Gladstone (XL Insurance)
  • Sean Griffith (Fordham University)
  • Irene Kim (Duke University)
  • Kevin LaCroix (Oakbridge Insurance Services)
  • Donald Langevoort (Georgetown University)
  • John McCarrick (Edwards Angell Palmer & Dodge LLP)
  • Ganapathi Narayanamoorthy (Yale University)
  • Edward Rock (University of Pennsylvania)
  • Roberta Romano (Yale Law School)
  • Andrew Schatz (Schatz Nobel Izard P.C.)
  • Keith Thomas (Zurich NA)
  • Robert Wallner (Milberg Weiss)
  • Thomas Wollstein (Munich Re)
Tags